Golden State Equity Partners Merck & Co., Inc. Transaction History
Golden State Equity Partners
- $182 Million
- Q3 2024
A detailed history of Golden State Equity Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 740 shares of MRK stock, worth $73,778. This represents 0.05% of its overall portfolio holdings.
Number of Shares
740
Previous 31,426
97.65%
Holding current value
$73,778
Previous $3.57 Million
97.65%
% of portfolio
0.05%
Previous 0.81%
Shares
14 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.9 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.56 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.9 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $253B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...